Tema Heart & Health ETF (NASDAQ:HRTS) Stock Price Up 0.2% – Time to Buy?
by Mitch Edgeman · The Markets DailyShares of Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report) were up 0.2% during trading on Friday . The company traded as high as $35.39 and last traded at $35.37. Approximately 1,447 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 8,234 shares. The stock had previously closed at $35.29.
Tema Heart & Health ETF Stock Up 0.2%
The stock has a market capitalization of $54.82 million, a PE ratio of 22.06 and a beta of 0.97. The firm’s fifty day moving average price is $34.57 and its two-hundred day moving average price is $31.44.
Tema Heart & Health ETF Announces Dividend
The company also recently declared a dividend, which was paid on Thursday, December 11th. Stockholders of record on Wednesday, December 10th were issued a dividend of $0.4729 per share. The ex-dividend date of this dividend was Wednesday, December 10th.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the company. CoreCap Advisors LLC increased its position in shares of Tema Heart & Health ETF by 25,280.4% during the 3rd quarter. CoreCap Advisors LLC now owns 51,776 shares of the company’s stock valued at $1,602,000 after purchasing an additional 51,572 shares during the last quarter. Jane Street Group LLC grew its position in Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after buying an additional 3,202 shares during the period. Oliver Lagore Vanvalin Investment Group purchased a new stake in Tema Heart & Health ETF during the second quarter valued at approximately $905,000. Citadel Advisors LLC bought a new position in Tema Heart & Health ETF in the third quarter worth approximately $243,000. Finally, JPMorgan Chase & Co. purchased a new position in shares of Tema Heart & Health ETF during the 2nd quarter worth $63,000.
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.